These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7657564)

  • 21. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.
    Dutta SK; Myrup A; Bumgardner MK
    Am J Vet Res; 1980 Dec; 41(12):2066-8. PubMed ID: 6259978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Not Available].
    Weitere Informationen bei: Albrecht GmbH – ein Unternehmen der Dechra Veterinary Products, 88323 Aulendorf, Tel.: (0 75 25) 205-0, E-Mail: info@dechra.com, www.dechra.de
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Feb; 46(1):65. PubMed ID: 29571207
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines for equine herpesvirus type 1.
    Studdert MJ
    Vet Rec; 1983 Apr; 112(14):334. PubMed ID: 6304985
    [No Abstract]   [Full Text] [Related]  

  • 26. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1986 Jul; 65(1):172-81. PubMed ID: 2431815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
    Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
    Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F; Nowotny N; Hofer A
    Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equine herpesvirus.
    Vet Rec; 1989 May; 124(19):519. PubMed ID: 2547266
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a vaccine against equine herpesvirus 1.
    Sabine M; Whalley JM
    Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative aspects of immunity against bovine and equine herpesviruses.
    McKercher DG; Saito JK; Mathis RM
    J Am Vet Med Assoc; 1969 Jul; 155(2):300-6. PubMed ID: 4307797
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equid herpesvirus 1 infection in mice.
    Inazu M; Tsuha O; Kirisawa R; Kawakami Y; Iwai H
    J Vet Med Sci; 1993 Feb; 55(1):119-21. PubMed ID: 8384894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin hypersensitivity to equid herpesvirus type 1 in horses.
    Frymus T; Woyciechowska S; Schollenberger A; Poliwoda A
    Zentralbl Veterinarmed B; 1978 Jun; 25(5):431-4. PubMed ID: 211756
    [No Abstract]   [Full Text] [Related]  

  • 39. Specificity of pseudorabies virus serotests.
    Neill JD; Kelling CL; Rhodes MB
    Am J Vet Res; 1984 Dec; 45(12):2675-6. PubMed ID: 6098206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epizootiologic studies of equine herpesvirus-1 infections by restriction endonuclease fingerprinting of viral DNA.
    Allen GP; Yeargan MR; Turtinen LW; Bryans JT; McCollum WH
    Am J Vet Res; 1983 Feb; 44(2):263-71. PubMed ID: 6299145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.